TNF-α polymorphisms in chronic beryllium disease and beryllium sensitization

Journal of Occupational and Environmental Medicine

Volumn 49, Issue 4, 2007, Pages 446-452

  McCanlies, Erin C ^a   Schuler, Christine R ^a   Kreiss, Kathleen ^a   Frye, Bonnie L ^a   Ensey, James S ^a   Weston, Ainsley ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERYLLIUM; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; BERYLLIOSIS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INDUSTRIAL WORKER; MAJOR CLINICAL STUDY; POPULATION RESEARCH; SENSITIZATION;

ALLELES; BERYLLIOSIS; BERYLLIUM; CHRONIC DISEASE; GENOTYPE; HLA-DP ANTIGENS; HUMANS; HYPERSENSITIVITY; LYMPHOCYTE ACTIVATION; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; RISK FACTORS; SEQUENCE ANALYSIS, PROTEIN; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES;

EID: 34247237259     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31803b9499     Document Type: Article

References (39)

1. Bauer RA, Sawyer RT, Daniloff E, Balkissoon R, Rose CS, Newman LS. Bronchoalveolar lavage macrophagelymphocyte clusters in granulomatous disease are linked to lymphocytosis. Sarcoidosis Vasc Diffuse Lung Dis. 2000;17:174-180.
2. Cullen MR, Cherniack MG, Kominsky JR. Chronic beryllium disease in the United States. Seminars in Respiratory Medicine. 1986;7:203-209.
3. McCanlies EC, Kreiss K, Andrew M, Weston A. HLA-DPB1 and chronic beryllium disease: a HuGE review. Am J Epidemiol. 2003;157:388-398.
4. Meyer KC. Beryllium and lung disease. Chest. 1994;106:942-946.
5. Deubner DC, Goodman M, Iannuzzi J Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey. Appl Occup Environ Hyg. 2001;16:521-526.
6. Deubner DC. Beryllium. J Occup Environ Hyg. 2005;2:D74-D78.
7. Wang Z, White PS, Petrovic M, et al. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. J Immunol. 1999;163:1647-1653.
8. Wang Z, Farris GM, Newman LS, et al. Beryllium sensitivity is linked to HLA-DP genotype. Toxicology. 2001;165:27-38.
9. Saltini C, Richeldi L, Losi M, et al. Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur Respir J. 2001;18:677-684.
10. Rossman MD, Stubbs J, Lee CW, Argyris E, Magira E, Monos D. Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am J Respir Crit Care Med. 2002;165:788-794.
11. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science. 1993;262:242-244.
12. Richeldi L, Kreiss K, Mroz MM, Zhen B, Tartoni P, Saltini C. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med. 1997;32:337-340.
13. McCanlies EC, Ensey JS, Schuler CR, Kreiss K, Weston A. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. Am J Ind Med. 2004;46:95-103.
14. Maier LA, Sawyer RT, Bauer RA, et al. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease. Am J Respir Crit Care Med. 2001;164:1192-1199.
15. Maier LA, McGrath DS, Sato H, et al. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol. 2003;171:6910-6918.
16. Maier LA. Genetic and exposure risks for chronic beryllium disease. Clin Chest Med. 2002;23:827-839.
17. Pennica D, Nedwin GE, Hayflick JS, et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 1984;312:724-729.
18. Jung HC, Eckmann L, Yang SK, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest. 1995;95:55-65.
19. Varela LM, Ip MM. Tumor necrosis factor-alpha: a multifunctional regulator of mammary gland development. Endocrinology. 1996;137:4915-4924.
20. Ware CF, Crowe PD, Grayson MH, Androlewicz MJ, Browning JL. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J Immunol. 1992;149:3881-3888.
21. Zhang M TK. Tumor necrosis factor. In: Thomson AW, ed. The Cytokine Handbook. New York: Academic press; 1998. p 517-548.
22. Hajeer AH, Hutchinson IV. TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech. 2000;50:216-228.
23. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol. 1999;66:562-566.
24. Allen RD. Polymorphism of the human TNF-alpha promoter - random variation or functional diversity? Mol Immunol. 1999;36:1017-1027.
25. Speer CP. Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr. 1999;158(Suppl 1):S18-S22.
26. Campbell DA, Li Kam Wa E, Britton J, Holgate ST, Markham AF, Morrison JF. Polymorphism at the tumour necrosis factor locus and asthma. Monogr Allergy. 1996;33:125-137.
27. Isomaki P, Punnonen J. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med. 1997;29:499-507.
28. James DG. Sarcoidosis 2001. Postgrad Med J. 2001;77:177-180.
29. Kornman KS, di Giovine FS. Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis. Ann Periodontol. 1998;3:327-338.
30. Moffatt MF, Cookson WO. Linkage and candidate gene studies in asthma. Am J Respir Crit Care Med. 1997;156:S110-S112.
31. Wilson AG, di Giovine FS, Duff GW. Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J Inflamm. 1995;45:1-12.
32. Wilson AG, Duff GW. Genetics of tumour necrosis factor in systemic lupus erythematosus. Lupus. 1996;5:87-88.
33. Henneberger PK, Cumro D, Deubner DD, Kent MS, McCawley M, Kreiss K. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health. 2001;74:167-176.
34. Kreiss K, Mroz MM, Newman LS, Martyny J, Zhen B. Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3. Am J Ind Med. 1996;30:16-25.
35. Kreiss K, Mroz MM, Zhen B, Wiedemann H, Barna B. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med. 1997;54:605-612.
36. Schuler CR, Kent MS, Deubner DC, et al. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med. 2005;47:195-205.
37. Kreiss K, Newman LS, Mroz MM, Campbell PA. Screening blood test identifies subclinical beryllium disease. J Occup Med. 1989;31:603-608.
38. Weston A, Willey JC, Modali R, et al. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci U S A. 1989;86:5099-5103.
39. Russell PJ. Population genetics. In: Davies G DK, ed. Genetics. New York: Harper-Collins; 2006. p 707-758.